ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
海西新药
143.100
+6.000
4.38%
手动刷新
成交量：
44.74万
成交额：
6,270.08万
市值：
112.63亿
市盈率：
70.67
高：
143.200
开：
138.200
低：
137.600
收：
137.100
52周最高：
169.300
52周最低：
97.500
股本：
7,870.73万
香港流通股本：
7,870.73万
量比：
3.12
换手率：
0.57%
股息：
- -
股息率：
- -
每股收益(LYR):
2.025
净资产收益率：
28.75%
总资产收益率：
12.62%
市净率：
18.34
市盈率(LYR):
70.67
市销率:
21.27
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字：
海西新药
交易所：
SEHK
成立时间：
2012
员工人数：
164
公司地址：
Floor 3 & 4, Block B,No. 177 Jinda Road,Jianxin Town,Cangshan District,Fuzhou,Fujian Province,China
官网：
http://www.hxpharma.com
邮编：
350028
电话：
86 591 8751 9936
传真：
- -
简介：
福建海西新药创制股份有限公司成立于2012年3月27日。公司是一家处于商业化阶段的制药公司,集研发、生产及销售能力于一体,具备在研创新药的管线。公司在中国最大、增长最快的治疗领域拥有多元化的产品组合及管线。截至最后实际可行日期,公司已商业化的产品组合主要包括用于消化系统疾病、心血管系统疾病、内分泌系统疾病、神经系统疾病及炎症疾病的仿制药。根据灼识咨询的资料,该等治疗领域占2023年中国医药销售总额的25%以上。公司的创新药管线专注于具有各种适应症的在研药物,包括一款潜在属同类首款的在研肿瘤药物、一款潜在用于治疗湿性年龄相关性黄斑变性(wAMD)╱糖尿病性黄斑水肿(DME)╱视网膜静脉阻塞(RVO)的首款口服药物及另外两款处于临床前阶段,用于治疗肿瘤及呼吸系统疾病的创新在研药物。公司所有在研创新药均由内部以专有方式开发及发展。
董事
名称
职位
康心汕
董事长，执行董事，战略委员会主席，薪酬与考核委员会委员，提名委员会主席
Feng Yan
执行董事，战略委员会委员
Chen Guangming
执行董事
陈枢仪
执行董事，营销顾问
龚为民
独立非执行董事，战略委员会委员，薪酬与考核委员会主席，审核委员会委员
王珊珊
独立非执行董事，提名委员会委员，审核委员会委员
蒲美婷
独立非执行董事，薪酬与考核委员会委员，提名委员会委员，审核委员会主席
许冬
非执行董事
王忻琨
非执行董事
陈霞
监事会主席，职工代表监事
吴江
股东代表监事
许丽霞
股东代表监事
股东
名称
职位
康心汕
总经理
Feng Yan
副总经理
Chen Guangming
副总经理，首席科学官
胡凯
副总经理，总裁助理
张俊环
财务总监，董事会秘书，联席公司秘书
刘国贤
联席公司秘书
陈霞
人力资源部经理，运营中心副主任
张明强
研发与全球事务总裁
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02637/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"海西新药","latestPrice":143.1,"timestamp":1774339698855,"preClose":137.1,"halted":0,"volume":447350,"delay":0,"changeRate":0.0437636761487965,"floatShares":78707270,"shares":78707270,"eps":2.024774,"marketStatus":"已收盘","change":6,"latestTime":"03-24 16:08:18","open":138.2,"high":143.2,"low":137.6,"amount":62700840,"amplitude":0.040846,"askPrice":143.1,"askSize":350,"bidPrice":142.6,"bidSize":200,"shortable":0,"etf":0,"ttmEps":2.264,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":137.1,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":3.123953,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"12.62%","roe":"28.75%","lyrEps":2.024774,"volumeRatio":3.123953,"shares":78707270,"dividePrice":0,"high":143.2,"amplitude":0.040846,"preClose":137.1,"low":137.6,"week52Low":97.5,"pbRate":"18.34","psRate":"21.27","week52High":169.3,"institutionHeld":0,"latestPrice":143.1,"committee":-0.272727,"eps":2.024774,"divideRate":0,"volume":447350,"delay":0,"ttmEps":2.264,"open":138.2,"prevYearClose":136,"prevWeekClose":137.3,"prevMonthClose":143,"prevQuarterClose":136,"fiveDayClose":141.9,"twentyDayClose":137.2,"sixtyDayClose":131.2,"earningDate":1774800000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2026-03-23","current":63.206714,"percent":0.509615,"low":41.43616,"twenty":67.276698,"median":69.716594,"eighty":73.462807,"high":84.764482,"avg":69.741797,"sd":6.293068,"marketCap":10790766717},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640},{"date":"2025-11-21","current":66.575785,"twenty":58.2567,"median":64.026746,"eighty":69.208194,"marketCap":9917116020},{"date":"2025-11-28","current":68.072175,"twenty":59.478322,"median":65.807152,"eighty":68.767812,"marketCap":10176850011},{"date":"2025-12-05","current":68.42835,"twenty":59.854834,"median":66.893861,"eighty":68.767812,"marketCap":10247686554},{"date":"2025-12-12","current":69.403659,"twenty":60.326406,"median":67.279459,"eighty":69.361692,"marketCap":10412971821},{"date":"2025-12-19","current":69.502155,"twenty":61.237436,"median":67.861589,"eighty":69.423358,"marketCap":10452325456},{"date":"2025-12-24","current":72.521094,"twenty":61.537644,"median":68.055113,"eighty":69.462757,"marketCap":10940310530},{"date":"2026-01-02","current":68.547,"twenty":62.032842,"median":68.254334,"eighty":69.697511,"marketCap":10381488913},{"date":"2026-01-09","current":76.256401,"twenty":63.533346,"median":68.54394,"eighty":70.33117,"marketCap":11577839417},{"date":"2026-01-16","current":83.450154,"twenty":64.030428,"median":68.594109,"eighty":71.180851,"marketCap":12711224105},{"date":"2026-01-23","current":75.203122,"twenty":64.243828,"median":68.851274,"eighty":73.407226,"marketCap":11444037058},{"date":"2026-01-30","current":72.029156,"twenty":65.345972,"median":69.26967,"eighty":73.580372,"marketCap":11011147073},{"date":"2026-02-06","current":69.741329,"twenty":66.631937,"median":69.18814,"eighty":73.524909,"marketCap":10688447266},{"date":"2026-02-13","current":69.700471,"twenty":66.864009,"median":69.376262,"eighty":73.289662,"marketCap":10743542355},{"date":"2026-02-20","current":69.085102,"twenty":66.878935,"median":69.376262,"eighty":72.984771,"marketCap":10633352177},{"date":"2026-02-27","current":72.331605,"twenty":67.046254,"median":69.403659,"eighty":72.584608,"marketCap":11255139610},{"date":"2026-03-06","current":63.89376,"twenty":67.046254,"median":69.448144,"eighty":72.584608,"marketCap":9862020931},{"date":"2026-03-13","current":75.4784,"twenty":67.193436,"median":69.633279,"eighty":73.562991,"marketCap":11703771049},{"date":"2026-03-20","current":69.956787,"twenty":67.26348,"median":69.715081,"eighty":73.483508,"marketCap":10806508171},{"date":"2026-03-23","current":69.726132,"twenty":67.276698,"median":69.716594,"eighty":73.462807,"marketCap":10790766717}],"updateTime":1774359986285},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":620979011,"yearFounded":2012,"employeeNum":164,"address":"Floor 3 & 4, Block B,No. 177 Jinda Road,Jianxin Town,Cangshan District,Fuzhou,Fujian Province,China","zipCode":"350028","officePhone":"86 591 8751 9936"},"stockCompanyDetail":{"websiteUrl":"http://www.hxpharma.com","stockEarnings":[{"period":"1week","weight":-0.0446},{"period":"1month","weight":0.0148},{"period":"3month","weight":0.0324},{"period":"6month","weight":0.5868},{"period":"ytd","weight":0.0081}],"compareEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.0806},{"period":"1year","weight":0.0292},{"period":"ytd","weight":-0.0487}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"福建海西新药创制股份有限公司成立于2012年3月27日。公司是一家处于商业化阶段的制药公司,集研发、生产及销售能力于一体,具备在研创新药的管线。公司在中国最大、增长最快的治疗领域拥有多元化的产品组合及管线。截至最后实际可行日期,公司已商业化的产品组合主要包括用于消化系统疾病、心血管系统疾病、内分泌系统疾病、神经系统疾病及炎症疾病的仿制药。根据灼识咨询的资料,该等治疗领域占2023年中国医药销售总额的25%以上。公司的创新药管线专注于具有各种适应症的在研药物,包括一款潜在属同类首款的在研肿瘤药物、一款潜在用于治疗湿性年龄相关性黄斑变性(wAMD)╱糖尿病性黄斑水肿(DME)╱视网膜静脉阻塞(RVO)的首款口服药物及另外两款处于临床前阶段,用于治疗肿瘤及呼吸系统疾病的创新在研药物。公司所有在研创新药均由内部以专有方式开发及发展。","exchange":"SEHK","name":"海西新药","nameEN":"HAIXI PHARMA"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":{"directors":[{"name":"康心汕","position":"董事长，执行董事，战略委员会主席，薪酬与考核委员会委员，提名委员会主席"},{"name":"Feng Yan","position":"执行董事，战略委员会委员"},{"name":"Chen Guangming","position":"执行董事"},{"name":"陈枢仪","position":"执行董事，营销顾问"},{"name":"龚为民","position":"独立非执行董事，战略委员会委员，薪酬与考核委员会主席，审核委员会委员"},{"name":"王珊珊","position":"独立非执行董事，提名委员会委员，审核委员会委员"},{"name":"蒲美婷","position":"独立非执行董事，薪酬与考核委员会委员，提名委员会委员，审核委员会主席"},{"name":"许冬","position":"非执行董事"},{"name":"王忻琨","position":"非执行董事"},{"name":"陈霞","position":"监事会主席，职工代表监事"},{"name":"吴江","position":"股东代表监事"},{"name":"许丽霞","position":"股东代表监事"}],"executives":[{"name":"康心汕","position":"总经理"},{"name":"Feng Yan","position":"副总经理"},{"name":"Chen Guangming","position":"副总经理，首席科学官"},{"name":"胡凯","position":"副总经理，总裁助理"},{"name":"张俊环","position":"财务总监，董事会秘书，联席公司秘书"},{"name":"刘国贤","position":"联席公司秘书"},{"name":"陈霞","position":"人力资源部经理，运营中心副主任"},{"name":"张明强","position":"研发与全球事务总裁"}]}}}